Engaged Capital exited its stakes in BlackLine (NASDAQ:BL) and Nevro (NYSE:NVRO) and took a new position in Chart Industries (NYSE:GTLS) in Q4 2024, among other moves.  The hedge fund, known for its ...

Physicians are voicing growing frustration with payer policies that delay payments, deny necessary care and add administrative burdens. From preauthorization headaches to reimbursement struggles, nine ...

The flu just won’t quit this year. The virus seemed to peak after the December holidays in Massachusetts, headed back down, ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Fourth-year medical students discuss skills learned beyond formal instruction; the things med school doesn’t teach.

The Japanese government has decided to digitalize and preserve the medical records of victims from the central Tokyo subway ...

On Tuesday February 18, at 1 PM, Cape Cod Healthcare will give a presentation on how to manage MyChart accounts at the Center ...

Validic, a leader in healthcare technology innovation, announces the launch of its patent-pending solution, a cutting-edge digital remote patient moni ...

Unless we support Pennsylvania’s pharmacists and make the profession attractive to the next generation, we could face a ...

Evidently, a clinical data intelligence platform, has tapped Kai Romero, MD, as its head of clinical success. This marks the first major hire since the organization closed its $15 million Series A ...

Having direct supervision or supervision through consultation, chart reviews and interaction assures patients have a trained physician involved in their care.

A trio of high-octane income stocks -- sporting an average yield of 6.65% -- can fatten investors' pocketbooks in 2025 (and ...